These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26195274)

  • 1. Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.
    Ho JH; Bailey GP; Archer JR; Dargan PI; Wood DM
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1185-96. PubMed ID: 26195274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45.
    Siddiqi S; Verney C; Dargan P; Wood DM
    Clin Toxicol (Phila); 2015 Jan; 53(1):54-9. PubMed ID: 25430506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of ethylphenidate in deaths in east and west Scotland.
    Parks C; McKeown D; Torrance HJ
    Forensic Sci Int; 2015 Dec; 257():203-208. PubMed ID: 26375622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven fatalities associated with ethylphenidate.
    Maskell PD; Smith PR; Cole R; Hikin L; Morley SR
    Forensic Sci Int; 2016 Aug; 265():70-4. PubMed ID: 26829338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR, 4,4'-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity.
    Glanville J; Dargan PI; Wood DM
    Hum Psychopharmacol; 2015 May; 30(3):193-8. PubMed ID: 25784180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance.
    Haden M; Archer JR; Dargan PI; Wood DM
    Subst Use Misuse; 2017 Jan; 52(2):223-232. PubMed ID: 27759479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Chasing the high" - experiences of ethylphenidate as described on international internet forums.
    Soussan C; Kjellgren A
    Subst Abuse; 2015; 9():9-16. PubMed ID: 25788832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The experience of an increase in the injection of ethylphenidate in Lothian April 2014-March 2015.
    Lafferty C; Smith L; Coull A; Shanley J
    Scott Med J; 2016 May; 61(2):74-83. PubMed ID: 27177553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).
    Wood DM; Dargan PI
    Clin Toxicol (Phila); 2012 Sep; 50(8):727-32. PubMed ID: 22882169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity.
    Owen DR; Wood DM; Archer JR; Dargan PI
    Drug Alcohol Rev; 2016 Sep; 35(5):591-6. PubMed ID: 26693960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nopaine no gain: recreational ethylphenidate toxicity.
    Bailey GP; Ho JH; Hudson S; Dines A; Archer JR; Dargan PI; Wood DM
    Clin Toxicol (Phila); 2015 Jun; 53(5):498-9. PubMed ID: 25871917
    [No Abstract]   [Full Text] [Related]  

  • 12. First detection of ethylphenidate in human fatalities after ethylphenidate intake.
    Krueger J; Sachs H; Musshoff F; Dame T; Schaeper J; Schwerer M; Graw M; Roider G
    Forensic Sci Int; 2014 Oct; 243():126-9. PubMed ID: 25161162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Internet snapshot study to compare the international availability of the novel psychoactive substance methiopropamine.
    Vermette-Marcotte AE; Dargan PI; Archer JR; Gosselin S; Wood DM
    Clin Toxicol (Phila); 2014 Aug; 52(7):678-81. PubMed ID: 25089723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity.
    Williard RL; Middaugh LD; Zhu HJ; Patrick KS
    Behav Pharmacol; 2007 Feb; 18(1):39-51. PubMed ID: 17218796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged mental health effects of ethylphenidate beyond cessation of use.
    Robertson R
    Addiction; 2017 Jan; 112(1):183-184. PubMed ID: 27936504
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of cognitive enhancers: methylphenidate and analogs.
    Carlier J; Giorgetti R; Varì MR; Pirani F; Ricci G; Busardò FP
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):3-15. PubMed ID: 30657540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L- and D-threo ethylphenidate concentrations, pharmacokinetics, and pharmacodynamics in horses.
    Knych HK; McKemie DS; Seminoff K; Hartmann P; Hovda L; Benson D
    Drug Test Anal; 2018 Oct; 10(10):1508-1517. PubMed ID: 29786965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol.
    Markowitz JS; DeVane CL; Boulton DW; Nahas Z; Risch SC; Diamond F; Patrick KS
    Drug Metab Dispos; 2000 Jun; 28(6):620-4. PubMed ID: 10820132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Availability of Modafinil and Methylphenidate Purchased from the Internet in the United Kingdom Without a Prescription.
    Hockenhull J; Wood DM; Dargan PI
    Subst Use Misuse; 2020; 55(1):56-65. PubMed ID: 31431114
    [No Abstract]   [Full Text] [Related]  

  • 20. Using internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4,4'-dimethylaminorex.
    Nizar H; Dargan PI; Wood DM
    J Med Toxicol; 2015 Mar; 11(1):80-4. PubMed ID: 25167967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.